Stacey May is the AAPS director of public outreach.
An estimated 1.2 million Americans are currently living with human immunodeficiency virus (HIV), with a fifth of them unaware of their condition. While these numbers are startling, people are working to discover ways of preventing HIV infection and putting an end to the increasing statistics.
Among the researchers at the 2012 AAPS Annual Meeting and Exposition is Patrick Kiser, who presented his poster today. In collaboration with colleagues from the University of Utah and CONRAD, a leading reproductive health research organization, Kiser has developed a new 90-day intravaginal ring that shows promise in HIV prevention.
This intravaginal ring enables the long-lasting vaginal delivery of tenofovir (TFV), the only topical prophylactic shown to be effective at reducing the sexual transmission of HIV when formulated in a short-lasting gel.
The ring can also be readily modified to deliver an anti-HIV agent and a contraceptive at the same time, making it a multi-purpose prevention technology.
Learn more about the research that Kiser and his team presented by viewing their abstract, no. T3165, in the 2012 AAPS Annual Meeting and Exposition MyAgenda Planner.